Effects of Orally Administered Lactoferrin and Lactoperoxidase-Containing Tablets on Clinical and Bacteriological Profiles in Chronic Periodontitis Patients

Table 2

Effects of bovine LF and LPO-containing tablets on clinical periodontal parameters.

Parameter	Group (𝑛)	Baseline	1 Week	4 Weeks	12 Weeks
PCR	Test (37)	58.33±2.15	55.14±1.80	52.36±1.94	50.53±2.29
	Control (35)	58.70±2.09	58.43±1.99	54.69±2.40	53.69±2.50
PlI	Test (74)	1.12±0.04	1.01±0.01	1.03±0.03	1.04±0.04
	Control (70)	1.04±0.02	1.07±0.03	1.01±0.03	1.06±0.03
GI	Test (74)	1.54±0.06	1.39±0.06	1.41±0.06	1.34±0.06
	Control (70)	1.47±0.06	1.30±0.06	1.37±0.06	1.34±0.06
BOP	Test (74)	56.76±5.80	40.54±5.75	40.54±5.75	36.49±5.63
	Control (70)	50.00±6.02	32.86±5.65	41.43±5.93	34.29±5.71
PD	Test (74)	4.97±0.14	4.69±0.11	4.58±0.10	4.16±0.09
	Control (70)	4.60±0.09	4.49±0.09	4.36±0.07	4.04±0.09
CAL	Test (74)	4.97±0.14	4.69±0.11	4.58±0.10	4.18±0.09
	Control (70)	4.60±0.09	4.49±0.09	4.36±0.07	4.04±0.09

Values represent the mean ± standard error.
PCR: plaque control record (%). PlI: plaque index. GI: gingival index. BOP: bleeding on probing (%). PD: probing depth (mm). CAL: clinical attachment level (mm).
PlI, GI, BOP, PD, and CAL were assessed in two teeth with chronic periodontitis per subject.